“When future generations ask us to tell the story of how we met the most pressing challenges of our time, what will we say? Will we tell them a story of regret? Or will we tell them a story of hope – of the power of imagination – a story about all the discoveries we made and the foundations we laid? How we co-created solutions that helped millions of people worldwide live longer, healthier lives.
How basic access to healthcare was no longer dependent upon the life you were born into or where you lived? How healthcare systems thrived – despite rising antimicrobial resistance, surging mental health issues, and the medical needs of an aging, less active population?
How we worked to prevent pandemics by controlling emerging and infectious diseases in animals? How we helped to treat and even protect against diseases in pets, horses, and livestock?
Or how we succeeded in preventing diseases in animals in the first place?” we read in an excerpt from a rhetorical questionnaire of pharmaceutical specialist BOEHRINGER INGELHEIM.
Mat NEIDHARDT c/o EMEIS DEUBEL photographed the ‘LIFE FORWARD’ campaign for BOEHRINGER INGELHEIM on commission for the agency Interbrand.
Boehringer Ingelheim has set its sights on changing the conversation about health while shifting the focus from the treatement of disease to adapting a more positive attitude towards health and well-being. The core of the evolved corporate brand, unwavering optimism, is designed to carry this message out into the world.
“Mat Neidhardt’s unique vision and artistic expertise made him the perfect choice for the job.” EMEIS DEUBEL, a visual communication and artist management agency representing talent in the areas of photography & film in Berlin.
Mat Neidhardt photographed the complete image pool for the new brand identity of Boehringer Ingelheim. Known for his ability to capture authentic, unfiltered moments, the campaign depicts genuine emotions and real people in real-life situations – all photographed by Mat with meticulous attention to detail.
Founded in 1885 by Albert Boehringer in Ingelheim on the Rhine, the pharmaceutical company Boehringer Ingelheim is the largest research-driven pharmaceutical company in Germany. The core business of Boehringer Ingelheim is the discovery, development, manufacture and marketing of innovative health care products for humans and animals.
Now operated in the fourth generation, the family-owned company achieved a revenue of EUR 25.6 billion in 2023. Its R&D expenditure amounted to EUR 5.8 billion. The Boehringer / von Baumbach family is among the ten most wealthiest in the world.
GoSee : boehringer-ingelheim.com
GoSee : emeisdeubel.com